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Editorial
[TheNTP]hadto be moreresponsive to criticalissues
inpublichealthpolicy.
Editorial
Public Health Policy and the National
Toxicology Program
Since its inception in 1978, the National Toxicology Program (NTP)
has made considerable progress toward achieving its goal of interna-
tional prominence based on excellence in toxicological studies. In the
early 1990s when we first developed significant interactions with the
NTP, we were struck by the reputation ofthe NTP in conducting and
reporting toxicological studies. Clearly, the NTP rodent bioassay was
and still is recognized as the standard for carcinogen identification,
without any close competition. The dedication of the NTP staff was
inspiring and is a tribute to the former Director ofthe NIEHS and the
NTP, David Rall. This objective, science-based approach to critical
issues in toxicology had a profound impact on emphasizing the link-
ages between basic science and public health policy in support of the
goals ofthe NTP which are to:
*Provide toxicological evaluation on substances of public health
concern
*Develop and validate improved methods (sensitive, specific, faster)
*Develop approaches and generate data to strengthen the science
base for risk assessments
*Communicate with all stakeholders.
As we immersed ourselves in the workings of the NTP, including
interactions with federal and state agencies, industry, and public inter-
est groups, we came to the realization that good toxicology was not
enough. The NTP needed to be more than a rodent-testing program.
It had to contribute more to strengthening the science base for risk
assessments, and it had to be more responsive to critical issues in pub-
lic health policy involving concerns over health effects of exposure to
chemical agents in our environment, at home and in the workplace, in
the food we eat, in the water we drink, and in the air we breathe. To
be successful, the NTP had to do three things. First, it had to broaden
and extend existing partnerships and develop new ones. The NTP's
two clients are the American public and governmental agencies at the
federal and state levels who rely on data from the NTP to make credi-
ble decisions in order to protect public health without increasing the
regulatory burden on American industry.
Second, the NTP had to embrace the concept ofmechanism-based
toxicology. The decision by the Secretary ofthe Department ofHealth
and Human Services (DHHS) in 1978 to center the NTP at the
NIEHS was for the explicit purpose ofcreating new opportunities for
taking advantage ofadvances in molecular biology and pharmacology
in order to understand how some chemicals can cause cancer, repro-
ductive and developmental effects, immune responses, and neurotoxi-
cology. It was clear that, in the early 1990s, much remained to be done
to develop the field ofmechanism-based toxicology.
Third, the reason why the NTP exists is to improve the nation's
ability to evaluate human health effects of chemical exposures.
Therefore, it is imperative that human data are used in toxicological
evaluations and that innovative approaches are developed in risk assess-
ment methodology to integrate data from diverse data sets, i.e., toxicol-
ogy, human studies, and mechanisms.
Some of the strategies for addressing these three issues are
briefly described below. Each of the specific initiatives presented
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have components of all three of the issues (mechanism-based toxi-
cology, human risk assessment, and partnerships), and this is how it
should be. The impetus for many of these new initiatives came not
only from personal convictions but also from an ad hoc review of
the NTP Board ofScientific Counselors commissioned in 1992 by
Kenneth Olden shortly after his appointment as Director of the
NIEHS and the NTP. Olden's vision, leadership, and commitment
to the concept ofgood science for good decisions have created the
ingredients and the environment for those of us who work for the
NTP to more effectively address public health concerns. The NTP
thanks the Boards of Scientific Counselors and other advisory
boards who give their time, energy, and advice on NTP priorities
and the credibility ofNTP science.
In January 1995, the NTP sponsored a workshop on Mechanism-
based Toxicology in Cancer Risk Assessment: Implications for
Research, Regulation, and Legislation. Theworkshop made five overall
recommendations, each of which has substantially influenced the
directions of the NTP, which are summarized here and discussed in
more detail in the meeting report (1).
1. Long-term bioassays for toxicity are costly and time-consuming,
so molecular studies can be used to prioritize which chemicals or
mixtures might be toxic. The NTP should use information on
mechanisms to set priorities by taking advantage of
chemical/biological interactions such as altered gene expression,
site-specific mutation, signal transduction pathways, and many
other molecular responses critical to toxicity.
2. In cases where the molecular/biological data is strong and com-
pelling, hazard or safety can be reasonably established in the
absence ofepidemiological data or rodent bioassays.
3. The use of mechanistic data should be used to decrease the
uncertainty in predicting dose-response relationships. This
approach is essential for improving the credibility ofquantitative
risk assessment.
4. The selection ofexperimental models most useful in human risk
assessments could be improved by careful consideration of
research on comparative mechanisms oftoxicity.
5. Identification of sensitive subpopulations based on factors such
as genetic predisposition, age, sex, nutrition, or co-exposure to
other chemicals requires research on the underlying mechanisms
responsible for the influence ofthose factors on risk. This infor-
mation provides the necessary foundation for replacing default
assumptions in riskassessmentwith real data.
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The NIEHS and the NTP have programs and projects in place to
address each of the five recommendations on mechanism-based toxi-
cology and risk assessment. In addition, we are working dosely with
regulatory agencies such as the EPA to implement guidelines for for-
mal use ofmechanistic data in riskassessment (2).
In 1978, the DHHS was mandated by Congress to develop a list of
agents that are "known" or "reasonably anticipated" to be human car-
cinogens to which a significant number ofpeople in the United States
are exposed. This responsibility was assigned to the NTP. Listings in
the first seven Reports on Carcinogens were based primarily on rodent
bioassays and human cancer data. In 1995, as part of the NTP initia-
tives in mechanism-based toxicology and risk assessment methodolo-
gies, the criteria for inclusion in the Report on Carcinogens were
reviewed in aseries ofpublic, scientific, and governmental meetings and
workshops. This process resulted in a revision ofthe criteria, which put
mechanistic data on an equal footing with human and animal cancer
data (3). These criteria were applied to the 8th Report on Carcinogens
and are being used in the 9th, currendy in preparation. These revised
criteria are impacting on the listing ofdioxin, benzidine dyes, and oth-
ers, and the proposed delisting ofsaccharin. It is not a risk assessment
document; however, the Report on Carcinogens is used by state and
federal regulatory agencies, and it is also an important mechanism for
alerting the public to potential cancer threats. The Report on
Carcinogens process is now more open and is based on the best science
available, therebyenhancing its use in public health policy.
The NIEHS has had a long and successful history ofdeveloping new
tests in toxicology through its extramural and intramural programs. One
recent advance has been the application oftransgenic animals as a com-
plement to chronic rodent bioassays for cancer (4). In 1993, the NIH
Revitalization Act mandated that the NIEHS also develop a process for
validation andregulatoryacceptance ofalternative testsystems (5,6). The
Interagency Coordinating Committee on the Validation ofAlternative
Methods is critical to theNTP'sabilityto successfully meet this mandate.
Also, the NTP is proud ofthe partnerships that have emerged from a
common goal to facilitate use oftoxicological tests that are faster, better,
less expensive, and refine, reduce, and replace animals used in research
whenever possible. We as scientists often work in the controversial arena
ofenvironmental health where polarized views confuse and mislead the
public. In contrast, interagency and public activities of the NTP in
achieving regulatory acceptance ofalternative tests are refreshingly colle-
gial; everyone is pulling in the same direction. Scientists like alternative
tests because they take advantage ofnew knowledge; groups interested in
decreasing animal use and minimizing pain and discomfort are enthusiasti-
cally supportive; industry likes them because better and more consistent
tests are available to determine safety ofproducts; regulatory agencies like
alternative tests because theyclarify a process that assists in the validation
andacceptanceofnewandimproved methods in regulatorydecision mak-
ing. Finally, thepubliclikes alternativetests because theprocess istranspar-
ent, scientific, and credible. The result can only lead to increased confi-
dence inthesafetyofawidearrayofproductsso integral toourdailylives.
There are manyother initiatives in the NTP worthy ofindusion here,
but space limitation precludes such a comprehensive discussion. Examples
indude the new Reproductive Toxicology Center (5), risk assessment
methodology innovations, the exposure initiative (7) and the
Environmental Genome Project. Please view the NTP web site (http.//ntp-
server.niehs.nih.gov) (8) for up-to-date information on NTP activities and
share your thoughts on NTP priorities and programs. After all, it is a
nationaltoxicologyprogram, soyourinvolvement isessential foritssuccess.
George W. Lucier
J. Carl Barrett
National Institute ofEnvironmental Health Sciences
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